New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
07:12 EDTCYCC
theflyonthewall.com: Cyclacel Pharmaceuticals to present Sapacitabine Phase 2 AML MDS data
Cyclacel Pharmaceuticals announced today that updated Phase 2 clinical trial results of sapacitabine for the treatment of advanced myeloid leukemia, AML, and myelodysplastic syndromes MDS, will be presented at two poster presentations during the 51st Annual Meeting of the American Society of Hematology in New Orleans, LA, on Saturday, December 5. :theflyonthewall.com



News For CYCC From The Last 14 Days
Check below for free stories on CYCC the last two weeks.
There are 4 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2010
09:00 EDTCYCC
theflyonthewall.com: On The Fly: Analysts Initiation Summary

Subscribe for More Information :theflyonthewall.com
06:25 EDTCYCC
theflyonthewall.com: Cyclacel Pharmaceuticals initiated with a Buy at Roth Capital

Subscribe for More Information :theflyonthewall.com

January 27, 2010
07:21 EDTCYCC
theflyonthewall.com: Cyclacel Pharmaceuticals regains Nasdaq compliance
Cyclacel Pharmaceuticals announced that NASDAQ notified the Company that it has regained compliance with the minimum $50 million market value of listed securities requirement, and further, that it currently complies with all other applicable standards for continued listing on The NASDAQ Global Market. :theflyonthewall.com

January 26, 2010
10:34 EDTCYCC
theflyonthewall.com: Rumor: Cyclacel moves up on speculation it will get NEJM mention

Subscribe for More Information :theflyonthewall.com